Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Operating Officer

Chief Financial Officer

Chief Executive Officer

Chief Scientific & Dev. Ofc.

SVP of Finance

SVP of Corp. Dev.

Chief Business Officer

SVP, Operations & Bus. Dev.

Interim CEO and President

SVP of Corp. Dev. & Ops & Sec.

President and CEO

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate for dim light or night vision disturbances; and for pharmacologically induced mydriasis and presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. The company is headquartered in Farmington Hills, Michigan.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-11	Premium	acquired	Premium	Premium	Premium	-
2024-03-21	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2024-03-21	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2024-03-18	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Scientific & Dev. Ofc.
2024-01-18	Premium	acquired	Premium	Premium	Premium	SVP of Finance
2024-01-18	Premium	acquired	Premium	Premium	Premium	SVP of Corp. Dev.
2024-01-10	Premium	sold (taxes)	Premium	Premium	Premium	Chief Business Officer
2024-01-10	Premium	sold (taxes)	Premium	Premium	Premium	SVP of Finance
2024-01-10	Premium	sold (taxes)	Premium	Premium	Premium	SVP of Corp. Dev.
2024-01-01	Premium	acquired	Premium	Premium	Premium	-
2024-01-01	Premium	acquired	Premium	Premium	Premium	-
2024-01-01	Premium	acquired	Premium	Premium	Premium	-
2024-01-01	Premium	acquired	Premium	Premium	Premium	-
2023-12-01	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2023-11-01	Premium	acquired	Premium	Premium	Premium	-
2023-11-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-11-01	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-06-06	Premium	acquired	Premium	Premium	Premium	-
2023-04-24	Premium	acquired	Premium	Premium	Premium	SVP, Operations & Bus. Dev.

OCUP - Ocuphire Pharma, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for OCUP